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The respiratory system is a complex organ system composed of multiple cell types involved in a
variety of functions. The development of the respiratory system occurs from embryogenesis to adult
life, passing through several distinct stages of maturation and growth. We review embryonic, fetal,
and postnatal phases of lung development. We also discuss branching morphogenesis and cellular
differentiation of the respiratory system, as well as the postnatal development of xenobiotic
metabolizing systems within the lungs. Exposure of the respiratory system to a wide range of
chemicals and environmental toxicants during perinatal life has the potential to significantly affect the
maturation, growth, and function of this organ system. Although the potential targets for exposure to
toxic factors are currently not known, they are likely to affect critical molecular signals expressed
during distinct stages of lung development. The effects of exposure to environmental tobacco
smoke during critical windows of perinatal growth are provided as an example leading to altered
cellular and physiological function of the lungs. An understanding of critical windows of exposure of
the respiratory system on children's health requires consideration that lung development is a
multistep process and cannot be based on studies in adults. Key words: branching morphogenesis,
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Development ofthe human respiratory system
involves the differentiation and proliferation
of over 40 different cell types as well as the
formation ofa highly ordered airway branch-
ing system with 25,000 distinct terminations
giving rise to more than 300 million alveoli.
The transition ofthe lungs from a simple pro-
truding bud oftissue from the foregut into a
highly organized, integrated, complex struc-
ture that is innervated, ventilated, and vascu-
larized is amultistep process.
The development of the lungs begins
with the evagination ofan avascular epithe-
lial bud and subsequent growth into sur-
rounding mesenchymal tissues. After
embryogenesis, the fetal lungs in all mam-
malian species undergo three anatomically
distinct stages ofgrowth termed pseudoglan-
dular, canalicular, and saccular (1). Although
the lungs have developed sufficiently to sus-
tain life at birth, growth is far from com-
plete. Approximately 80% of alveoli in the
adult lung arise postnatally. In essence, lung
development is a continuum from embryo-
genesis through early adolescence.
The stages oflung development are con-
trolled by a variety offactors that modulate
the timing and pattern ofcellular prolifera-
tion and differentiation as well as branching
morphogenesis. Recent reviews by Hackett
and Gitlin (2), Shannon and Deterding (3)
and Ramon (4) stress the importance of a
number of transcription factors, molecular
signals, and soluble factors in orchestrating
the developmental process ofthe respiratory
tract. These molecular signals are expressed
in both temporal and spatial patterns to
facilitate normal lung development and to
regulate epithelial-mesenchymal interac-
tions, cellular proliferation, extracellular
matrix deposition and composition, growth
factor and receptor expression, and cell-to-
cell interactions.
Exposure to a variety oftoxicants and/or
conditions during lung development has the
potential to significantly affect the overall
growth and function of the respiratory sys-
tem. The target ofa toxic insult to the lungs
during development is likely to involve the
disruption and/or alteration ofa specific mol-
ecular signal or transcription factor, but to
date, little information is available as to the
precise effect ofsuch exposures. However,
timing of exposure during development
appears to be critical in the subsequent effects
observed. For example, maternal malnutrition
during gestation may significantly retard fetal
growth and the development of the lungs,
leading to compromised lung function
throughout life. In contrast, exposure to envi-
ronmental toxicants such as secondhand ciga-
rette smoke may actually accelerate the
maturation ofspecific cell types in the fetal
lung (5), but the effects ofsuch a change on
overall lung function are unknown in the
newborn through adulthood.
A number of studies suggest that the
processes ofcellular differentiation, branching
morphogenesis, and overall lung growth can
be affected by exposure to chemicals. The
effects ofexposure, however, are likely to be
different for each period ofdevelopment. For
example, during embryogenesis and fetal
development, cell number, cell type, and cell
function of the airways and alveoli may be
significantly affected by exposure to a diverse
number of substances and/or conditions.
Both embryogenesis and fetal gestation repre-
sent critical periods ofcellular differentiation
and branching morphogenesis. However,
because cells continue to differentiate and
divide during the postnatal period, chemical
exposure during the postnatal period is also
likely to affect the respiratory system but in a
different manner based on changes in the
process ofdifferentiation and morphogenesis
(6). Because growth is essentially complete
by the end ofadolescence, exposure to chem-
icals and other factors are likely to have com-
pletely different consequences in the adult
compared to children (6-8).
Abnormal developmental changes that
occur in the perinatal period because ofexpo-
sure to a variety ofchemicals and/or condi-
tions may have long-term effects persisting
into adult life. Exposure to substances during
critical windows ofdevelopment may have
profound effects that would not be seen ifthe
same exposure were to occur in the adult.
Because lung development occurs over the
entire perinatal period, exposure effects can
have significant consequences whether they
occur during the pre- or postnatal period of
life. However, our current understanding of
these changes is extremelylimited.
The purpose of this paper is to examine
critical windows ofexposure affecting the res-
piratory system and children's health. We
describe each stage ofthe respiratory system
during pre- and postnatal development,
beginningwith embryogenesis and fetal gesta-
tion. Postnatal development through puberty
will be examined. We discuss health out-
comes as a result of exposure during these
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time periods, and we consider a comparison
ofsimilarities and differences between humans
and animals andgaps in ourknowledge.
Lung Development
The beginning of lung growth occurs in
embryogenesis. In humans, the formation of
the lungs starts near the end of the first
month ofgestation, and the pseudoglandu-
lar, canalicular, and saccular stages ofdevel-
opment follow in sequential periods of
approximately 10-12 weeks each, respec-
tively (Table 1) (9,10). A similar pattern of
lung development is also observed in other
mammalian species, although the timing and
onset ofeach stage are considerably different
based on the actual length ofthe gestational
period and the relative degree oflung matu-
ration at birth (10,11).
Embryogenesis
The lungs in humans first appear at the end
ofthe first month ofgestation as an evagina-
tion ofepithelium from the foregut. The bud
rapidly divides as a series ofbranching tubes
in a dichotomous pattern. These tubular
branches invade and interdigitate with mes-
enchymal tissues. Branching morphogenesis
during this period forms the most proximal
portions ofthe future tracheobronchial tree.
As these tissues grow, they push into the
future pleuroperitoneal cavityofthe embryo.
During embryogenesis, transcription fac-
tors play an important role in gene expres-
sion and regulation. Transcription factors
are essential in both the stimulation and
inhibition ofgene expression to regulate the
proper temporal and spatial patterning of
lung development. Hepatocyte nuclear fac-
tor-3 (12) and the homeobox gene TTF-1
(13) are examples of transcription factors
serving as important regulators ofearly dif-
ferentiation of the pulmonary epithelium
during this period.
Lung development is also highly depen-
dent on interactions between the epithelium
and mesenchyme. This dual origin oflung
tissues is critical in development. Removal of
mesenchyme from the tip ofa lung bud dur-
ing early phases ofdevelopment with trans-
plantation to the side of a higher ordered
segment abolishes further branching at the
site ofremoval while stimulating growth ofa
new branch at the site of transplantation
(14). Lung vascularization arises from bud-
ding ofvessels from the aortic arches and
connection to the vascular plexes forming
within the pulmonary mesenchyme.
FetalLmngDevelopment
Lung development during fetal gestation is
categorized into three stages: pseudoglandu-
lar, canalicular, andsaccular.
Pseudoglandudarsige. Tubularbranching
of the human lung airways continues from
the fifth to the seventeenth week ofgestation.
As early as 2 months ofgestational age, all
segmental bronchi are present. During this
period, the lungs take on the appearance ofa
glandlike structure. This stage is the most
critical for the formation ofall conducting
airways. During this period, the airway tubu-
lar structures are lined with tall columnar
epithelium, whereas the more distal structures
are linedwith cuboidal epithelium.
Anumberofsignalsarisingfromepithelial-
mesenchymal interactions during this time
continue to modulate cellular proliferation
temporally as well as spatially (4). These reg-
ulatory signals lead to further branching
morphogenesis by affecting the rate ofcellu-
lar proliferation (15). The presence ofextra-
cellular matrix molecules, including
collagen, fibronectin, laminin, glycosamino-
glycans, and proteoglycans, as well as cell
membrane-bound integrins, also plays an
important role in directing lung develop-
ment by influencing the rates ofcellular pro-
liferation and differentiation (3,16,1/).
Mechanical distention exerted on the lung as
well as on specific cell types can also signifi-
cantly affect gene expression and, ultimately,
lung growth and development (4). A variety
ofgrowth factors and growth factor recep-
tors are also important in controlling cellular
functions (3). Epidermal growth factor,
transforming growth factor-a, and retinoic
acid all act to affect branching morphogene-
sis and cellular differentiation (18,19).
Epithelial differentiation of ciliated,
goblet, and basal cells first appears in the
most central airways during this stage of
development. Cartilage and smooth muscle
cells are also first noted in the trachea and
extend more peripherally with progressive
growth of the lungs. During this stage of
Table 1. Development offetal lungs.
Gestational age(days)
Species Term Embryonic Pseudoglandular Canalicular Saccular
Human 280 < 42 52-112 112-168 168
Mouse 20 < 9 16 18 19
Rat 22 < 13 16-19 19-20 21
Rabbit 32 < 18 21-24 24-27 27
Sheep 150 <40 40-80 80-120 120
Primate 168 <42 57-80 80-140 140
Modified from Meyrick and Reid(9) and Fanucchi and Plopper (101.
development, the vascular tree develops
along with the bronchial tree. Pulmonary
arteries follow the branching pattern ofthe
airways, whereas the veins run within the
mesenchyme to define the margins offuture
lung segments and subsegments.
Canalicular stage. This stage lasts from
week 16 to week 24 in the human fetus.
Lung morphology changes dramatically dur-
ing this time because ofdifferentiation ofthe
pulmonary epithelium, resulting in the for-
mation ofthe future air-blood tissue barrier.
Surfactant synthesis and the canalization of
the lung parenchyma by capillaries begin.
During this stage, the future gas exchange
regions can be easily distinguished from the
future conducting airways ofthelungs.
Sacculrstage. The saccular stage oflung
development in humans lasts from week 24
to near term. The most peripheral airways
form widened airspaces, termed saccules.
These saccules widen and lengthen the air-
space, in large measure by the addition of
new generations. During this stage, the future
gas exchange region expands significantly.
Populations offibroblastic cells also undergo
differentiation during this stage. These
fibroblast-like cells are responsible for the
production ofthe extracellular matrix, colla-
gen, and elastin. It is also presumed that they
play an important role in epithelial differenti-
ation and control ofsurfactant secretion in
connection with the growth of the gas
exchange region during this stage. The vascu-
lar tree also grows in length and diameter
during this time.
Branching morphogenesis. Branching
morphogenesis reflects the pattern offetal lung
development continuing into the postnatal
period, characterized bytheenlargement ofthe
airways and gas exchange regions by repeated
branching and outgrowth of tissues from
rapidly dividing epithelial buds. This growth
occurs in a radial pattern beginning from the
original tracheobronchial mass and extending
outward to form multiple future conducting
airways before forming the gas exchange por-
tions ofthe lungs. Branchingmorphogenesis is
a continuous process, playing a critical role in
all stages of fetal lung development. As
reflected in the stages ofdevelopment (i.e.,
pseudoglandular, canalicular, and saccular),
conducting airways as well as the ventilatory
units forming the gas exchange portions ofthe
lungs can only be formed through a process of
branchinggrowth.
The branching offuture airways and gas
exchange regions of the lungs is critically
dependent on factors expressed within the
mesenchyme into which these epithelial buds
invade (4,15,16). Budding and branching
processes involve differential factors that reg-
ulate focal cell proliferation, as well as
changes in epithelial shape and differentiation
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(4,19). Factors within the mesenchyme,
particularly those present in the extracellular
matrix, are influential in directing branching
morphogenesis. Fibronectin, laminin, and
tenascin are specific extracellular matrix com-
ponents thought to play critical roles in this
process (20-22). Growth of the lungs by
tubular epithelial branching may be regulated
by a variety ofsubstances such as epidermal
growth factor, transforming growth factor-a,
and retinoic acid (4,19).
Organized interaction between the epithe-
lial, interstitial, and vascular compartments
forming the gas exchange portion ofthe lungs
is critical to the overall growth, development,
and formation ofalveolar structures. The syn-
thesis and laying down ofextracellular matrix
including collagen and elastin are critical in
creating the scaffolding on which epithelial
cells and the capillary bed intertwine to form
alveolar shapes that are maintained through-
outlife (in the absence ofdisease).
The process ofalveolarization is an exten-
sion ofsaccular formation begun in the late
gestational period, identified by the forma-
tion ofsecondary alveolar septa arising from
primary alveolar septa (Figure 1). In all
species, alveolarization continues postnatally.
In species with short gestational periods, birth
occurs before the formation oftrue alveoli in
the lungs. Therefore, in some species alveolar-
ization can be considered only a postnatal
event (Table 2). In species with longer peri-
ods of gestational development, saccular
formation is superseded by the formation of
new alveoli before birth. In these species, true
alveolar structures are present at birth.
Although the timing ofalveolarization differs
among species, the formation ofnew alveoli
continues as a postnatal process in all
mammalian species.
Postnatal LungDevelopment
The formation of new alveoli is critical for
continued growth of the lungs into early
adulthood. An increase in body mass from
birth to adulthood is accompanied by increas-
ing metabolic demands of the organism.
Therefore, to meet the metabolic needs ofthe
organism during postnatal growth, lung
growth must parallel increases in body mass.
A number of studies have demonstrated a
strong allometric relationship among lung
volume, alveolar surface area, and body mass
over awide range ofmammalian species (23).
Allometric relationships support the concept
that there is a dose relationship among these
parameters and that they must be maintained
in a similar manner to ensure the proper
exchange ofgases between the environment
and the organism.
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Cellulardifferentiation. Cellular differ-
entiation ofthe lungs continues throughout
the lifespan of all species; however, this
process is most evident during the fetal and
early postnatal periods. Little is known about
the mechanisms that regulate cellular differ-
entiation. Cellular differentiation begins in
the proximal airways and progresses in a
radial fashion down the growing airways.
Differentiation ofthe tracheal epithelium has
been most extensively studied in the respira-
tory system. Asummary ofthis differentiation
process and the timing for the appearance ofa
variety ofepithelial cell typeswithin the devel-
oping tracheais shown in Figure 2 (24).
Columnar cells that are undifferentiated
characterize the first epithelial cells lining
fetal lung tubules. The first epithelial cells to
differentiate in the trachea are neuroen-
docrine cells, followed closely by ciliated
cells, and finally basal and secretory cells in
rapid sequence. This process ofdifferentia-
tion covers a developmental period ranging
from days to months. In rodents including
the mouse, rat, and hamster, complete
illgranule)
Mature ciliated
hnn
Mature secretory
Mature basal
Differentiating
basal
Figure 1. Centriacinar region from the fetal lung of a
near-term pig with the parenchymal walls undergoing
the process of alveolarization. Short buds of secondary
alveolar septa (arrows) extend out from thick primary
alveolar septa to form a future alveolarduct.
Table 2. Formation of alveoli in perinatal lungs.
Species Onset Completion
Human 252 DGA 730 DPN (2 years)
Mouse 1-2 DPN 28 DPN
Rat 1-4 DPN 28 DPN
Rabbit 30 DGA ?
Sheep 120 DGA ?
Primate 155 DGA 365 DPN (1 year)
Abbreviations: ?, unknown; DGA, days gestational age; DPN,
days postnatal age.
Mouse
Hamster
Rat
Rabbit
1 *- 25% - a (5 days)
1 *- 12.5% - a (2 days)
1*- 20%---> n
(4.5 days)
1 * 40%- , (13 days)
Rhesusmonkey 1+* ------------------70% -----------
(118 days)
Human I *----------75% -------> c (26weeks)
Species Duration of gestation (%) (days) Bi
(dL
irth
Figure 2. Comparative analysis of cellular differentiation of the tracheal epithelium. Reproduced from Plopper et al.
(24), with permission of the American College of Chest Physicians. This analysis is based on a summary of studies
in six species: mouse, hamster, rat, rabbit, rhesus monkey, and human. In these species, cells undergoing ciliogene-
sis occur before the beginning of secretory and basal cell differentiation. The absolute length of time (in days) and
the percentage of gestation during which the process occurs prenatally is estimated based on the time of first
appearance of ciliated cells.
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epithelial differentiation ofthe trachea occurs
in as little as 2 days. In primate trachea, cel-
lular differentiation takes up to 6 months to
be complete. In most species, epithelial cell
differentiation of the trachea usually is not
complete until just before birth. For more
peripheral airway generations, cellular differ-
entiation is likely to continue into the early
postnatal period.
Fetal epithelial cells aretypicallyfilledwith
glycogen that is gradually replaced with a
granular cytoplasm filled with numerous
organelles during cellular differentiation.
These glycogen-filled cells are found through-
out the tracheobronchial tree as well as into
the most peripheral saccules. Differentiation
ofthe epithelium is highly site specific, giving
rise to more than 10 different cell types. For
example, within the saccules ofthe lungs, cells
lining these surfaces differentiate to form both
squamous type 1 cells as well as cuboidal type
2 cells. The presence ofglycogen within these
cells maypersist into earlypostnatal life.
Because cellular differentiation occurs in a
radial fashion beginning at the trachea, the
more distal airways undergo cellular differen-
tiation at a later time during gestation. A
number ofcells in the more distal airways
possess specific metabolic functions including
the nonciliated bronchiolar epithelial (Clara)
cell. In the fetal state these cells contain abun-
dant amounts ofglycogen. Maturation ofthis
cell is characterized by the formation ofabun-
dant amounts ofsmooth and roughendoplas-
mic reticulum in the basolateral and apical
regions of the cell cytoplasm that occur
almost exclusively during the early postnatal
period. Recent studies suggest that changes in
the subcellular structure ofcells coincide with
the first expression ofmetabolic function.
These sequences ofcellular differentiation
and maturation reflect the fact that the new-
born respiratory system is far from being
developed and completely functional at birth.
Changes must continue through thepostnatal
period before the lungs attain characteristics
ofthe adult lungs.
Development oflungxenobiotic metab-
olizing enyzme systems. Many of the
enzymes that play a critical role in lung
metabolism are not fully developed at birth.
A number ofthese enzymes are responsible
for both the activation and detoxification of
xenobiotic compounds. Among the most
important enzyme systems to develop during
the mid to late gestational periods through
early childhood are the glutathione S-trans-
ferases (25) and epoxide hydrolases (26).
Antioxidant enzymes including superoxide
dismutase, catalase, and glutathione peroxi-
dase also appear during this period (27-29).
A highly critical family of isozymes
involved in the bioactivation and detoxi-
fication ofxenobiotic compounds is the
cytochrome P450 monooxygenase system.
The developmental profile ofthe cytochrome
P450 monooxygenase system closely coincides
with changes in subcellular composition of
Clara cells and endothelial cells during the late
gestational and earlypostnatal period ofdevel-
opment. Although this family ofisozymes
may first appear near the end ofgestation,
they are more likely to develop during the
postnatal period. A number ofstudies showed
that early postnatal exposure to environmental
toxicants can alter the developmental profile
for these isozymes (30).
Potential Targets ofToxic
Agents during Lung
Development
The effects ofmany toxicants on the respira-
tory system have been well characterized in
the adult, but less is known in the developing
lung. A number oftoxicants affect the devel-
oping lungs. These include environmental
tobacco smoke (ETS) (5,30-33), bioacti-
vated compounds (6-8), and oxidant gases
(34,35). The target for a number of these
compounds is in large measure airway
epithelial cells undergoing maturation and/or
rapid proliferation. However, the precise
mechanism leading to greater sensitivity of
these cells in the neonate compared to the
adult is still unknown.
Administration ofsteroids during lung
development can also alter the normal process
oflung maturation (36,34. The most likely
target cell is the epithelial cell that may be
altered by an accelerated maturation and a
reduction in the rate ofproliferation. Our
knowledge ofthe precise effects ofchemicals
on lungdevelopment is still extremelylimited.
In addition to toxicants, it is also important to
keep in mind that nutritional deficiency can
also significantly alterlungdevelopment (38).
ETS
The lungs are extremely sensitive to a large
number ofinhaled toxicants (39). ETS is an
excellent example of an airborne pollutant
that contains many ofthese toxicants. ETS is
defined as a combination ofexhaled main-
stream smoke and sidestream smoke (SS)
given offfrom the smoldering end ofa ciga-
rette. A strong relationship has been demon-
strated between respiratory illness in young
children and ETS exposure (31).
Exposure to ETS is also associated with
significant risks in the development and/or
exacerbation ofasthma, airway hyperrespon-
siveness, and other respiratory symptoms
such as cough, wheeze, and mucus produc-
tion. Epidemiological studies suggest that
exposure to smoke during the perinatal
period may have adverse effects on lung
function that can persist into adulthood.
However, the mechanisms leading to this
process are unknown.
Recent studies from our laboratory (32)
have used various exposure regimens to aged
and diluted SS as a surrogate to ETS to deter-
mine the existence of critical windows of
exposure during the perinatal period ofdevel-
opment. Timed pregnant rats were exposed
to environmentally relevant concentrations of
SS using a concentration of 1 mg/m3 total
suspended particulates. We examined timed
pregnant dams under the following four
exposure regimens: a) exposure to SS only
during the in utero period, b) exposure to SS
only during the postnatal period, c) exposure
to SS during both in utero and postnatal peri-
ods, and d) exposure to filtered air during
both in utero and postnatal periods. All rat
offspringwere examined at 7-10 weeks ofage
(32). Animals exposed to SS during both the
in utero and postnatal periods exhibited
marked alterations in airway sensitivity
(Figure 3) and pulmonary neuroendocrine
cell (PNEC) frequency (Figure 4) in contrast
to animals that had been exposed to SS only
during the prenatal period or only to SS dur-
ing the postnatal period but not both. We
hypothesized that these changes are due to SS
exposure during critical windows oflung
growth and development that include both
fetal and early postnatal periods oflife. Such
exposure conditions are not uncommon in
humans and appear to be essential for airway
hyperresponsiveness to develop.
Because differences noted in this study
could also be attributed to the duration of
exposure rather than the timing ofexposure,
we tested the hypothesis that early exposure
to ETS during the perinatal period is
sufficient to produce a lasting response into
adulthood. Maternal exposure to SS was
begun on gestational day 5, followed by con-
tinued exposure to SS duringthe first 3 weeks
oflife. At 8 weeks ofage, the airway reactivity
ofthese animals was markedly increased com-
pared to the lungs ofrats exposed only to fil-
tered air (Figure 5), despite the absence ofSS
exposure from 3 to 8 weeks ofage (33). This
model appears highly analogous to the devel-
opment ofpulmonaryfunction decrements in
children exposed to tobacco smoke during
the perinatal period (40,41). Therefore, this
animal model affords the opportunity to
examine more preciselycritical periods during
lung development when exposure to SS leads
to increased airway responsiveness and
whether changes in PNEC number and/or
function might be responsible for these
changes. Critical windows ofexposure during
the perinatal period that affect airway reactiv-
ity are clearly defined in these experimental
studies, but thelong-term effects ofsuch peri-
natal exposures into adulthood are not
known (Figure 6).
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Figure 3. Methacholine-induced changes in lung resis-
tance after differential timing of exposure to ETS during
the perinatal period of life. Abbreviations: FA, filtered
air; SS, sidestream cigarette smoke. Rats were exposed
to FA and/or aged and diluted SS using four different
timing regimens: a) exposure to FA during both in utero
and postnatal periods (FA/FA), b) exposure to SS only
during the postnatal period (FA/SS), c) exposure to SS
only during the in utero period (SS/FA), and a) exposure
to SS during both in utero and postnatal periods
(SS/SS). Reproduced from Joad et al. (32), with permis-
sion ofAcademic Press, Inc.
*Repeated measures analysis of variance on log-transformed
data demonstrated a statistically significant difference (p<0.05)
between SS/SS and all other exposure groups.
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No change in airway reactivity ?
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Figure 6. Diagram of critical windows of exposure to
ETS during lung development. Horizontal lines represent
timing of exposure to ETS. In rats, exposure began as
early as gestational day 5 (fetal) and continued through
postnatal day 60 (adolescence). Some exposures ended
by 21 days postnatal age (neonatal). Airway reactivity in
all instances was measured at 60 days postnatal age.
The results of these experimental studies suggest that
the timing of exposure to cigarette smoke is critical to
the biological outcome of increased airway reactivity
when measured in adolescence. This critical period of
exposure includes both in uteroand early postnatal peri-
ods of life. However, the consequences of perinatal
exposure to cigarette smoke in the adult are unknown.
Conclusions
To better understand the potential effects of
critical windows of exposure in children on
the respiratory system, it is important to
consider the following factors that character-
ize the process oflung development. First,
lung development is a multievent process
that is not restricted to prenatal life.
Although the lungs undergo dramatic
changes during the embryonic, pseudoglan-
dular, canalicular, and saccular stages, the
majority ofchanges to the lungs continue
postnatally during the process of alveolari-
zation. Second, only a limited number of
maturational events must be finished at
birth for successful survival ofthe organism.
EJ
U 20-
e 15-
M1EA EWSS:.,. .SWFA .,S$IS
Ehposu. rogimen
Figure 4. Pulmonary neuroendocrine cell number per
centimeter basal lamina length in the airways of rats
after differential exposure to ETS. Abbreviations: FA, fil-
tered air; SS, sidestream cigarette smoke. Neuro-
endocrine cells were identified by neuron-specific
enolase staining (32). Labeling of each exposure group is
identical to thatfound in Figure 3.
Those animals exposed to SS/SS had significantly greater num-
bers of neuroendocrine cells compared to all other groups, as
indicated bythe brackets (p<0.01).
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Figure 5. Methacholine-induced changes in lung resis-
tance with perinatal exposure prenatal and 3 weeks post-
natal to aged and diluted sidestream smoke (ADSS) or to
FA followed by 5 weeks of exposure to FA. Repeated
measures analysis of variance on log-transformed data
demonstrated persistent airway hyperresponsiveness in
animals exposed to ADSS compared to animals exposed
only to FA (p < 0.02). Reproduced from Joad et al. (33),
with permission ofAcademic Press, Inc.
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Figure 7. Respiratory effects associated with timing of exposure. Although little information is currently available, a
variety of respiratory health outcomes may occur with perinatal exposure to environmental and chemical toxicants
and be manifested throughout life. For each respiratory health outcome shown, the solid horizontal line represents
the potential window of exposure leading to this effect.
Third, cellular differentiation, branching
morphogenesis, and overall growth define
lung development during both the pre- and
postnatal periods. Finally, all of these devel-
opmental events occur in the presence of an
increasing mass oftotal cells.
Gaps in Our Knowledge
The susceptibility ofchildren to exposure to
a wide range ofenvironmental toxicants can-
not be based on studies in adults. Cellular
differentiation, cellular proliferation, and cel-
lular physiological function ofthe lungs are
continually changing during gestational and
postnatal growth. The sensitivity of these
cells and their responses to environmental
insults are likely to be completely different
compared to those found in the adult. The
route ofdelivery of an environmental toxi-
cant to the respiratory system is completely
different during the fetal period compared to
the postnatal period. Influences of passage
through other organ systems and the vascula-
ture as well as through maternal organ sys-
tems must be taken into consideration. Our
knowledge base regarding perinatal exposure
and critical windows is negligible (Figure 7).
Without question, there is still much to be
learned about the effects oftoxicants on gene
regulation, molecular signaling, and growth
factors during lung development. Without
the careful control and proper timing of
expression for these factors, growth could
become misdirected and chaotic. Future
studies must be designed to address these
critical windows of exposure to provide
meaningful answers for the benefit ofhealthy
children into adulthood.
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